Stabilized compositions containing non-glysylated human tissue type plasminogen activator derivative K2P pro
US5352452A · kind A · utility
5Cited by
7References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 1991 |
| Grant date | Oct 4, 1994 |
| Priority date | — |
| Expiry date | Aug 2, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Stabilized compositions containing a non-glycosylated human tissue type plasminogen activator derivative are disclosed. The derivative is referred to as K2P pro. The composition has enzymatic activity of at least 1.1 mU/ml, a pH of from 4.5 to 6.5, and contains citrate as well as at least one of a variety of different compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.